These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 19350120)

  • 1. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
    Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
    Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer.
    Devetzi M; Trangas T; Scorilas A; Xynopoulos D; Talieri M
    Thromb Haemost; 2013 Apr; 109(4):716-25. PubMed ID: 23224034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
    Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
    J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
    Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM
    Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
    Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
    Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J
    Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
    Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
    Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
    Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
    Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthine oxidoreductase - clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells.
    Linder N; Martelin E; Lundin M; Louhimo J; Nordling S; Haglund C; Lundin J
    Eur J Cancer; 2009 Mar; 45(4):648-55. PubMed ID: 19112016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
    Alexopoulou DK; Papadopoulos IN; Scorilas A
    Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer].
    Feng B; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Qu Y; Li JW; Lu AG; Wang ML; Liu BY; Zhu ZG
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):623-7. PubMed ID: 16784657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
    Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
    Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering the clinical impact of kallikrein-related peptidase 5 (KLK5) mRNA expression in the colorectal adenoma-carcinoma sequence.
    Papachristopoulou G; Malachias A; Devetzi M; Kamouza E; Scorilas A; Xynopoulos D; Talieri M
    Clin Chem Lab Med; 2019 Jul; 57(8):1251-1260. PubMed ID: 30759066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer.
    Planque C; de Monte M; Guyetant S; Rollin J; Desmazes C; Panel V; Lemarié E; Courty Y
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1260-6. PubMed ID: 15766562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.